Biochemical Mechanisms beyond Glycosphingolipid Accumulation in Fabry Disease: Might They Provide Additional Therapeutic Treatments?

Fabry disease is a rare X-linked disease characterized by deficient expression and activity of alpha-galactosidase A (α-GalA) with consequent lysosomal accumulation of glycosphingolipid in various organs. Currently, enzyme replacement therapy is the cornerstone of the treatment of all Fabry patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Bertoldi, Giovanni, Caputo, Ilaria, Driussi, Giulia, Stefanelli, Lucia Federica, Di Vico, Valentina, Carraro, Gianni, Nalesso, Federico, Calò, Lorenzo A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10004377/
https://www.ncbi.nlm.nih.gov/pubmed/36902850
http://dx.doi.org/10.3390/jcm12052063

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10004377/
https://www.ncbi.nlm.nih.gov/pubmed/36902850
http://dx.doi.org/10.3390/jcm12052063

Ejemplares similares